Background. To investigate the association between insulin resistance (IR) and cardiovascular disease (CVD) risks among hemodialysis patients. Methods. We conducted a cross-sectional study between 2013 and 2017, on 384 hemodialysis patients from seven hospital-based-dialysis centers. HOMA-IR is classified according to median value. The CVD risks were defined by the K/DOQI Guidelines. Logistic regression analysis was used. Results. Patients' age was 60.9 ± 11.8, 58.1% men, and 40.3% overweight/obese. The median of HOMA-IR was 5.4, 82.8% high systolic blood pressure, and 85.7% hyperhomocysteinemia. In multivariate analysis, IR was significantly associated with higher odds of low high-density lipoprotein cholesterol, high triglyceride, and impaired fasting glucose in groups of normal weight, overweight/obese, nondiabetes, diabetes, and overall sample. IR linked with elevated high-sensitive C-reactive protein in normal weight patients (odd ratio, OR=2.21, 95% confidence interval, 1.16-4.22, p <.05), with hypoalbuminemia in normal weight patients (OR=8.31, 95% CI, 2.35-29.37, p <.01), in nondiabetes patients (OR=6.59, 95% CI, 1.81-23.95, p <.01), and overall sample (OR=3.07, 1.51-6.23, p <.01). Conclusions. The level of IR and prevalence of CVD risks were high in hemodialysis patients. IR was independently associated with CVD risks.
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Immunology and Microbiology(all)
Duong, T. V., Shih, C. K., Wong, T. C., Chen, H. H., Chen, T. H., Hsu, Y. H., Peng, S. J., Kuo, K. L., Liu, H. C., Lin, E. T., Su, C. T., & Yang, S. H. (2019). Insulin Resistance and Cardiovascular Risks in Different Groups of Hemodialysis Patients: A Multicenter Study. BioMed Research International, 2019, 1541593. . https://doi.org/10.1155/2019/1541593